So-Soo-Yoo®

The Phase IIb research is a multicenter ou acheter priligy.

BioInvent, ThromboGenics initiate TB-402 Stage IIb trial for VTE prophylaxis ThromboGenics NV and co-advancement partner BioInvent International announce today that the initial patient offers been dosed in a Stage IIb trial with their novel long-performing anticoagulant TB-402 for the prophylaxis of venous thromboembolism after total hip medical procedures. The Phase IIb research is a multicenter, dual blind, randomised managed trial ou acheter priligy le-priligy.com . It really is comparing the security and efficacy of two dosage levels of TB-402, given as an individual intravenous infusion after hip medical operation, with the lately approved Aspect Xa inhibitor rivaroxaban.